SCHEMBL8107069

SCHEMBL8107069

Cc1cccc(-c2ccc(Cc3ncc(Cc4ccc(C#N)cc4)[nH]3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 5/20 0.51
CYP11B1 P15538 1/20 0.48
CYP11B2 P19099 1/20 0.48
MAPK14 Q16539 1/20 0.43
KDM1A O60341 1/20 0.42
HRH3 Q9Y5N1 4/20 0.41
VNN1 O95497 1/20 0.40
MARK3 P27448 1/20 0.38
GSK3A P49840 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7919393 0.88 BRS3 (0.62) BRS3CYP11B1CYP11B2HRH3GRIN1
SCHEMBL8106523 0.88 BRS3 (0.54) BRS3CYP11B1CYP11B2KDM1AHRH3
SCHEMBL8097365 0.87 BRS3 (0.50) BRS3HRH3TSHRMAPT
Hydrochloric Acid SCHEMBL8521500 0.87 BRS3 (0.61) BRS3CYP11B1CYP11B2HRH3GRIN1
Hydrochloric Acid SCHEMBL8305721 0.86 BRS3 (0.49) BRS3HRH3TSHRMAPT
SCHEMBL8097324 0.84 BRS3 (0.48) BRS3VNN1KDM4EGRIN1GRIN2B
Hydrochloric Acid SCHEMBL8306295 0.84 BRS3 (0.47) BRS3VNN1KDM4EGRIN1GRIN2B
SCHEMBL8106541 0.82 BRS3 (0.46) BRS3KDM1AGRIN1GRIN2B
SCHEMBL8105207 0.82 BRS3 (0.53) BRS3CYP11B1CYP11B2HRH3TSHR
Bromide SCHEMBL8309405 0.81 BRS3 (0.45) BRS3KDM1AGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0986302-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-03-22 EP claimed
WO-1998054966-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1998-12-10 WO claimed
EP-0986302-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-03-22 EP disclosed
EP-0891333-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1999-01-20 EP disclosed
WO-1998054966-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1998-12-10 WO disclosed
WO-1997036875-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-10-09 WO disclosed